BRONCHIECTASIS

Clinical trials for BRONCHIECTASIS explained in plain language.

Never miss a new study

Get alerted when new BRONCHIECTASIS trials appear

Sign up with your email to follow new studies for BRONCHIECTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 16 Not yet recruiting 3 Not yet finished but already full! 4 Completed 4 Terminated 1

Drug trial halted early in bid to clear lungs of chronic infection

Disease control Terminated

This study tested an oral drug called QBW251 to see if it could help adults with bronchiectasis, a chronic lung condition. The goal was to see if the drug could improve lung function, reduce mucus, and lower the amount of harmful bacteria in the lungs. The trial was stopped early…

Matched conditions: BRONCHIECTASIS

Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

BRONCHIECTASIS

Get alerted when new BRONCHIECTASIS trials appear

Drug trial halted early in bid to clear lungs of chronic infection